Integrative Neuroscience Section, Integrative Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, NIDA/IRP 333 Cassell Dr., Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2010 Jun;210(2):231-40. doi: 10.1007/s00213-010-1799-6. Epub 2010 Mar 16.
Kappa-opioid receptor (KOR) agonists produce dysphoria and psychotomimesis in humans. KORs are enriched in the prefrontal cortex and other brain regions that regulate mood and cognitive function. Dysregulation of the dynorphin/KOR system has been implicated in the pathogenesis of schizophrenia, depression, and bipolar disorder. Prepulse inhibition of the acoustic startle reflex (PPI), a sensorimotor gating process, is disrupted in many psychiatric disorders.
The present study determined whether KOR ligands alter PPI in rats.
Utilizing a range of doses of the synthetic KOR agonists (+/-) U50,488, (-) U50,488, and U69,593 and the naturally occurring KOR agonist, Salvinorin A, we demonstrate that KOR activation does not alter PPI or startle reactivity in rats. Similarly, selective KOR blockade using the long-acting antagonist nor-binaltorphimine (nor-BNI) was without effect. In contrast to KOR ligands, MK-801 and quinpirole produced deficits in PPI. Stress and corticotropin-releasing factor (CRF) decrease PPI levels. The dynorphin/KOR system has been suggested to be a key mediator of various behavioral effects produced by stress and CRF. We therefore examined the contribution of KORs to CRF-induced alterations in PPI. Intracerebroventricular infusion of CRF decreased PPI. Administration of nor-BNI failed to affect the CRF-evoked disruption in PPI.
Together, these results provide no evidence of a link between the dynorphin/KOR system and deficits in sensory gating processes. Additional studies, however, examining whether dysregulation of this opioid system contributes to cognitive deficits and other behavioral abnormalities associated with psychiatric disorders are warranted.
κ-阿片受体(KOR)激动剂会在人类中引起不适和幻觉。KOR 在调节情绪和认知功能的前额皮质和其他大脑区域中丰富。内啡肽/KOR 系统的失调与精神分裂症、抑郁症和双相情感障碍的发病机制有关。听觉惊跳反射(ASR)的前脉冲抑制(PPI),一种感觉运动门控过程,在许多精神疾病中受到破坏。
本研究旨在确定 KOR 配体是否会改变大鼠的 PPI。
利用一系列剂量的合成 KOR 激动剂(+/-)U50,488、(-)U50,488 和 U69,593 以及天然存在的 KOR 激动剂 Salvinorin A,我们证明 KOR 激活不会改变大鼠的 PPI 或惊跳反应。同样,使用长效拮抗剂诺比那嗪(nor-BNI)选择性阻断 KOR 也没有效果。与 KOR 配体相反,MK-801 和喹吡罗导致 PPI 缺陷。应激和促肾上腺皮质激素释放因子(CRF)降低 PPI 水平。内啡肽/KOR 系统被认为是应激和 CRF 产生的各种行为效应的关键介质。因此,我们研究了 KOR 对 CRF 诱导的 PPI 改变的贡献。脑室内注射 CRF 会降低 PPI。给予 nor-BNI 未能影响 CRF 诱发的 PPI 破坏。
综上所述,这些结果没有提供内啡肽/KOR 系统与感觉门控过程缺陷之间存在联系的证据。然而,需要进一步研究,以确定该阿片系统的失调是否会导致与精神疾病相关的认知缺陷和其他行为异常。